Efficacy and safety of autologous platelet-rich plasma in anal fistula: a systematic review and meta-analysis.
Ann Saudi Med
; 44(4): 264-271, 2024.
Article
em En
| MEDLINE
| ID: mdl-39127896
ABSTRACT
INTRODUCTION:
This study aimed to determine the efficacy and safety of autologous PRP in anal fistula.METHODS:
The search was done in electronic databases such as; PubMed, Scopus, Google Scholar, Embase, and Cochrane Library. The outcomes investigated in this study were the rate of improvement, the rate of recurrence, and the rate of fecal incontinence.RESULTS:
Cure, incontinence, and recurrence rates were 68% (95% CI, .60-.76), 27% (95% CI, .12-.46), and 18% (95% CI, .12-.26), respectively. The pooled improvement ratio in patients treated with PRP compared to control group was 1.35 times, which was statistically significant (pooled OR=1.35, 95% CI, 1.14-1.60, P<001). The pooled recurrence ratio in patients treated with PRP compared to control group was 1.17, which was not statistically significant (pooled OR=1.17, 95% CI, 0.44-3.11).DISCUSSION:
Platelet-rich plasma is an effective method of healing people with anal fistula.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Recidiva
/
Fístula Retal
/
Plasma Rico em Plaquetas
/
Incontinência Fecal
Limite:
Humans
Idioma:
En
Revista:
Ann Saudi Med
Assunto da revista:
MEDICINA
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
China